Cargando…

Bipolar androgen therapy (BAT): A patient's guide

Bipolar androgen therapy (BAT) is a new treatment concept for men whose prostate cancer has become resistant to standard hormone‐blocking therapy. Over the past decade, we have performed a series of clinical studies testing BAT in asymptomatic men with castration‐resistant prostate cancer. The key f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denmeade, Samuel, Antonarakis, Emmanuel S, Markowski, Mark C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313844/ https://www.ncbi.nlm.nih.gov/pubmed/35357024 http://dx.doi.org/10.1002/pros.24328

Ejemplares similares

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss
por: Markowski, Mark C., et al.
Publicado: (2022)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022)

Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres
por: Zarbá, Martín, et al.
Publicado: (2022)

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies
por: Sfanos, Karen S., et al.
Publicado: (2018)

Germline genetic testing in prostate cancer – further enrichment in variant histologies?
por: Markowski, Mark C., et al.
Publicado: (2018)

Enzalutamide: the emperor of all anti-androgens
por: Antonarakis, Emmanuel S.
Publicado: (2013)

The Influence of Prednisone on the Efficacy of Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Teply, Benjamin A., et al.
Publicado: (2015)

Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire
por: Nabavi, Nima, et al.
Publicado: (2023)

Role of androgen receptor splice variant 7 (AR-V7) in prostate cancer resistance to 2(nd) generation androgen receptor signaling inhibitors
por: Zhu, Yezi, et al.
Publicado: (2020)

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
por: Peinetti, Nahuel, et al.
Publicado: (2022)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
por: Shore, Neal D., et al.
Publicado: (2020)

From bench to bedside: bipolar androgen therapy in a pilot clinical study
por: Zhang, Qing, et al.
Publicado: (2015)

Androgen Receptor Variant–Driven Prostate Cancer II: Advances in Laboratory Investigations
por: Lu, Changxue, et al.
Publicado: (2020)

CCAAT/Enhancer Binding Protein β Controls Androgen Deprivation-Induced Senescence in Prostate Cancer Cells
por: Barakat, David J., et al.
Publicado: (2015)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
por: Boudadi, Karim, et al.
Publicado: (2016)

Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancer
por: Akinboye, Emmanuel S., et al.
Publicado: (2019)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion
por: Tran, Phuoc T., et al.
Publicado: (2017)

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
por: Antonarakis, Emmanuel S., et al.
Publicado: (2016)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
por: Sena, Laura A., et al.
Publicado: (2021)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
por: Johnson, Matthew E., et al.
Publicado: (2012)

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy
por: Moyad, Mark A, et al.
Publicado: (2016)

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
por: Chen, Jiayu, et al.
Publicado: (2023)

Androgen Therapy in Neurodegenerative Diseases
por: Bianchi, Vittorio Emanuele, et al.
Publicado: (2020)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

Making a bat: The developmental basis of bat evolution
por: Sadier, Alexa, et al.
Publicado: (2021)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

When to start aripiprazole therapy in patients with bipolar mania
por: Sayyaparaju, Kiran Kumar, et al.
Publicado: (2014)

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
por: Hussain, Arif, et al.
Publicado: (2020)

Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
por: Markowski, Mark C, et al.
Publicado: (2015)

Autophagy in Prostate Cancer and Androgen Suppression Therapy
por: Ziparo, Elio, et al.
Publicado: (2013)

Bats and Coronaviruses
por: Banerjee, Arinjay, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p73c7hbvomb2lq28n58argd19h